Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,204,449
+$1,652,633 QoQ
Shares Held
215,945
+57.7% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#45
of 172 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Derivatives in MLTX
reported options exposure · as of Jun 30, 2026CallValue
$1,947,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. MLTX ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in MLTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,204,449 | 215,945 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,947,000 | 100,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $2,551,816 | 136,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,337,335 | 101,467 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $4,328,312 | 328,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $527,200 | 40,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $266,724 | 37,200 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $472,000 | 10,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $781,400 | 20,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $572,922 | 14,664 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $814,888 | 16,162 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $798,802 | 18,167 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $859,284 | 17,107 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||